COMMONWEALTH OF AUSTRALIA
National Health Act 1953
PHARMACEUTICAL BENEFITS
DECLARATION UNDER SUBSECTION 85(2AA)
No. PB 11 of 2004
I, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953 hereby make the following Declaration:
1. This Declaration commences on 1 August 2004.
2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.
THE SCHEDULE
Cisapride Monohydrate
Dexamethasone with Framycetin Sulfate and Gramicidin
Diclofenac Potassium
Ergotamine Tartrate with Caffeine
Heparin Calcium
Polygeline
Polymyxin B Sulfate with Neomycin Sulfate and Gramicidin
Polyvinyl Alcohol with Povidone
Pyridoxine Hydrochloride
Dated this twelfth day of July 2004.
JOAN CORBETT
Assistant Secretary
Pharmaceutical Benefits Branch
Department of Health and Ageing
Delegate of the Minister for Health and Ageing